Nestin expression as a new marker in malignant peripheral nerve sheath tumors

Pathology International

Volumn 57, Issue 2, 2007, Pages 60-67

  Shimada, Satoko ^a   Tsuzuki, Toyonori ^b   Kuroda, Makoto ^d   Nagasaka, Tetsuro ^a   Hara, Kazuo ^e   Takahashi, Emiko ^c,e   Hayakawa, Seijun ^f   Ono, Kenzo ^g   Maeda, Nagako ^b   Mori, Naoyoshi ^a   Illei, Peter B ^h  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^f ANJO KOSEI HOSPITAL   (Japan)

^g TOSEI GENERAL HOSPITAL   (Japan)

^h DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Immunohistochemistry; Malignant peripheral nerve sheath tumor; Nestin

Indexed keywords

BIOLOGICAL MARKER; CD56 ANTIGEN; NESTIN; PROTEIN; PROTEIN GENE PRODUCT 9.5; PROTEIN S 100; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOSARCOMA; CONTROLLED STUDY; DERMATOFIBROMA; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NERVE SHEATH TUMOR; NEURILEMOMA; NEUROFIBROMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SCHOOL CHILD; SPINDLE CELL CARCINOMA; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; CAUDA EQUINA; CELL TRANSFORMATION, NEOPLASTIC; CHILD; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LEIOMYOSARCOMA; MALE; MELANOMA; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NERVE TISSUE PROTEINS; NEURILEMMOMA; RHABDOMYOSARCOMA; SARCOMA; SCHWANN CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846951844     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2006.02059.x     Document Type: Article

References (31)

1. Woodruff JM, Kourea HP, Louis DN, Scheithauer BW. Malignant peripheral nerve sheath tumor (MPNST). In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press, 2000; 172-4.
2. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-95.
3. Tohyama T, Lee VM, Rorke LB, Marvin M, McKay RD, Trojanowski JQ. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest 1992; 66: 303-13.
4. Dahlstrand J, Lardelli M, Lendahl U. Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Brain Res Dev Brain Res 1995; 84: 109-29.
5. Friedman B, Zaremba S, Hockfield S. Monoclonal antibody rat 401 recognizes Schwann cells in mature and developing peripheral nerve. J Comp Neurol 1990; 295: 43-51.
6. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 1992; 52: 5334-41.
7. Smits A, van Grieken D, Hartman M, Lendahl U, Funa K, Nister M. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation. Lab Invest 1996; 74: 188-98.
8. Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, Viskochil DH. Malignant peripheral nerve sheath tumor: A comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol 2003; 27: 1337-45.
9. Tsujimura T, Makiishi-Shimobayashi C, Lundkvist J et al. Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal. Am J Pathol 2001; 158: 817-23.
10. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006; 19: 659-68.
11. Nakajima T, Watanabe S, Sato Y, Kameya T, Shimosato Y, Ishihara K. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application. Cancer 1982; 50: 912-18.
12. Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest 1983; 49: 299-308.
13. Bojsen-Moller M, Myhre-Jensen O. A consecutive series of 30 malignant schwannomas. Survival in relation to clinicopathological parameters and treatment. Acta Pathol Microbiol Immunol Scand (A) 1984; 92: 147-55.
14. Arpornchayanon O, Hirota T, Itabashi M et al. Malignant peripheral nerve tumors: A clinicopathological and electron microscopic study. Jpn J Clin Oncol 1984; 14: 57-74.
15. Matsunou H, Shimoda T, Kakimoto S, Yamashita H, Ishikawa E, Mukai M. Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma). Cancer 1985; 56: 2269-79.
16. Daimaru Y, Hashimoto H, Enjoji M. Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases. Am J Surg Pathol 1985; 9: 434-44.
17. Wick MR, Swanson PE, Scheithauer BW, Manivel JC. Malignant peripheral nerve sheath tumor. An immunohistochemical study of 62 cases. Am J Clin Pathol 1987; 87: 425-33.
18. Hirose T, Hasegawa T, Kudo E, Seki K, Sano T, Hizawa K. Malignant peripheral nerve sheath tumors: An immunohistochemical study in relation to ultrastructural features. Hum Pathol 1992; 23: 865-70.
19. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol 1992; 16: 694-707.
20. Sangueza OP, Requena L. Neoplasms with neural differentiation: A review. Part II. Malignant neoplasms. Am J Dermatopathol 1998; 20: 89-102.
21. Takeuchi A, Ushigome S. Diverse differentiation in malignant peripheral nerve sheath tumours associated with neurofibromatosis-1: An immunohistochemical and ultrastructural study. Histopathology 2001; 39: 298-309.
22. Stark AM, Buhl R, Hugo HH, Mehdorn HM. Malignant peripheral nerve sheath tumours: Report of 8 cases and review of the literature. Acta Neurochir (Wien) 2001; 143: 357-63; discussion 63-4.
23. Hoshi N, Sugino T, Suzuki T. Regular expression of osteopontin in granular cell tumor: Distinctive feature among Schwannian cell tumors. Pathol Int 2005; 55: 484-90.
24. Watanabe T, Oda Y, Tamiya S, Masuda K, Tsuneyoshi M. Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components. J Clin Pathol 2001; 54: 631-6.
25. Hoang MP, Sinkre P, Albores-Saavedra J. Expression of protein gene product 9.5 in epithelioid and conventional malignant peripheral nerve sheath tumors. Arch Pathol Lab Med 2001; 125: 1321-5.
26. Campbell LK, Thomas JR, Lamps LW, Smoller BR, Folpe AL. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: An immunohistochemical study of 95 mesenchymal neoplasms. Mod Pathol 2003; 16: 963-9.
27. Sarlomo-Rikala M, Tsujimura T, Lendahl U, Miettinen M. Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas. APMIS 2002; 110: 499-507.
28. Kobayashi M, Sjoberg G, Soderhall S, Lendahl U, Sandstedt B, Sejersen T. Pediatric rhabdomyosarcomas express the intermediate filament nestin. Pediatr Res 1998; 43: 386-92.
29. Sejersen T, Lendahl U. Transient expression of the intermediate filament nestin during skeletal muscle development. J Cell Sci 1993; 106: 1291-300.
30. Florenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O. Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res 1994; 54: 354-6.
31. Allison KH, Patel RM, Goldblum JR, Rubin BP. Superficial malignant peripheral nerve sheath tumor: A rare and challenging diagnosis. Am J Clin Pathol 2005; 124: 685-92.